Quince Therapeutics
Quince Therapeutics is a clinical stage pharmaceutical company developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Quince Therapeutics is targeting a specific, undisclosed pathogen tied to neurodegeneration. The target has been validated in a number of animal models and Cortexyme is currently testing several potential lead therapeutics in preclinical studies.
Domain
quincetx.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$22.0M
Founded
2011
Tech Stack (12 technologies)
Frequently Asked Questions
What technologies does Quince Therapeutics use?+
Quince Therapeutics uses 12 technologies including WordPress, jQuery, jQuery Migrate.
What industry is Quince Therapeutics in?+
Quince Therapeutics operates in the Biotechnology industry.
Where is Quince Therapeutics based?+
Quince Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026